Loading
Syncona Limited Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest was filed 22 Jun 2026.
Syncona Limited: what insiders have been doing
Syncona Limited is a listed company. Its directors and officers file their transactions with RNS (LSE). Between 18 October 2025 and 18 October 2026, 1 insider published 1 filing.
The flow runs one way only: 1 insider bought (1 purchase totalling €18k) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 board member. One trade stands out by size: a purchase of €18k from John Patrick Roche, disclosed on 22 June 2026.
For context, the typical company on the same exchange (median of 833 companies) published 6 filings over the same period, against 1 filing here. Since 2024, the database holds 3 purchases and no sales by insiders of the company.
The latest purchase dates back some time: it was published 117 days ago, on 22 June 2026.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€53,545
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJohn Patrick Roche2 buys
Since the insiders bought
- +29.6%Entry £0.95 · Close 13 Oct 2026 £1.24
- -14.9%Entry £1.09 · Close at T+365 £0.93
- -16.2%Entry £1.10 · Close at T+365 £0.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,605 of 24,148 companies
29.9
score / 100
Value41
Quality18
FCF yld3.1%
Earn yld-1.2%
EV/EBITDA·
ROE-0.8%
Gross mgn·
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
£1.23
Analyst consensus
2 analysts1.00/5
£1.89Target £2.02(+64%)£2.15
Income statement
Revenue£55.9M
Net income-£8.8M-43.4% margin
Valuation
P/Book72.2x
Beta0.29
Balance sheet & cash
Market cap£749.3M
Free Cash Flow£23.3M
Debt / Equity10%
Profitability & ownership
ROE-0.8%
ROA-0.3%
% insiders1.2%
% institutions63.6%
Last declaration on 22 June 2026
Declarations3 total
16,063 shares@ £0.996100.0% of flowLondon Stock ExchangeISIN GG00B8P59C08RNS:608417f9-22b6-4ccb-97b0-c46d875714ff
Canonical exit: 17 Sept 2026 (T+90)
26,573 shares@ £1.116100.0% of flowLondon Stock ExchangeISIN GG00B8P59C08RNS:5240823
Canonical exit: 23 Sept 2024 (T+90)
0100.0% of flowLondon Stock ExchangeISIN GG00B8P59C08RNS:5237474
Canonical exit: 22 Sept 2024 (T+90)
3 of 3 declarations
About Syncona Limited
Syncona Limited is an investment company focused on the life sciences sector, dedicated to developing innovative therapies. It is listed on the London Stock Exchange under the ticker XLON.
